Literature DB >> 7867673

General practitioners for rational use of drugs. Examples from Sweden.

Y Tomson1, A Wessling, G Tomson.   

Abstract

In the south west region of Stockholm a group of 125 general practitioners (GPs) at 27 health centres asked about the extent to which the drug formulary of the University Hospital was useful in their practices. To answer this question, the GPs asked their local pharmacies for prescribing data. When presented this started a process towards rational prescribing from within the group of GPs, including repeated prescribing surveys, starting with health centres as the unit of analysis and proceeding to individual prescribing analyses on request by the GPs. As the prescribing data revealed major differences between health centres, the GPs arranged two workshops on drug use in primary health care. They developed a list of 167 recommended drugs based on drug statistics and morbidity in general practice. Signs of increased cost cautiousness could be shown. There was a clear trend towards both smaller volumes and cost per prescription item for the health centres in the study area. Compared to the national prescribing pattern, prescribing practice in the study area represented a 20 per cent lower drug cost. Although the GPs decided on a drug list separate from that of the hospital, collaboration between the Drug and Therapeutic Committee at the hospital and the GPs increased as a result of their increased engagement in drug management, thereby also bridging the gap between primary health care and clinical pharmacology.

Mesh:

Year:  1994        PMID: 7867673     DOI: 10.1007/bf02570500

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  13 in total

Review 1.  Quality assurance for drug prescribing.

Authors:  S B Soumerai; T J McLaughlin; J Avorn
Journal:  Qual Assur Health Care       Date:  1990

2.  Clinical pharmacology and primary health care in Europe--a gap to bridge. The WHO Working Group on Clinical Pharmacology in Europe.

Authors:  G Dukes; P K Lunde; A Melander; M Orme; F Sjöqvist; G Tognoni; H Wesseling
Journal:  Eur J Clin Pharmacol       Date:  1990       Impact factor: 2.953

3.  Pharmacists to the fore.

Authors:  B Hammarström; B Westerholm
Journal:  World Health Forum       Date:  1988

4.  Attitudes to development of drug therapy in Scandinavia.

Authors:  F Sjöqvist; G Boethius
Journal:  Br J Clin Pharmacol       Date:  1986       Impact factor: 4.335

5.  Development of a limited formulary for general practice.

Authors:  G B Grant; D A Gregory; T D van Zwanenberg
Journal:  Lancet       Date:  1985-05-04       Impact factor: 79.321

6.  Effect of clinical guidelines on medical practice: a systematic review of rigorous evaluations.

Authors:  J M Grimshaw; I T Russell
Journal:  Lancet       Date:  1993-11-27       Impact factor: 79.321

7.  Scientific versus commercial sources of influence on the prescribing behavior of physicians.

Authors:  J Avorn; M Chen; R Hartley
Journal:  Am J Med       Date:  1982-07       Impact factor: 4.965

Review 8.  Drug utilization studies and people. A Swedish perspective.

Authors:  G Tomson
Journal:  Ann Ist Super Sanita       Date:  1991       Impact factor: 1.663

9.  Continuous recording of drug prescribing in Sweden 1974-1983. Methods and examples of utilization of data.

Authors:  A Wessling
Journal:  Eur J Clin Pharmacol       Date:  1987       Impact factor: 2.953

10.  Some patterns of prescribing by urban general practitioners.

Authors:  H McGavock
Journal:  Br Med J (Clin Res Ed)       Date:  1988-03-26
View more
  4 in total

Review 1.  Drug prescription in Italy.

Authors:  M Maggini; R Raschetti; G Traversa
Journal:  Eur J Clin Pharmacol       Date:  1996       Impact factor: 2.953

2.  Profile of drug use in urban and rural India.

Authors:  B Dineshkumar; T C Raghuram; G Radhaiah; K Krishnaswamy
Journal:  Pharmacoeconomics       Date:  1995-04       Impact factor: 4.981

3.  [Effectiveness of a personalized information system on the quality of family doctors' medical prescription].

Authors:  J J López-Picazo Ferrer; J A Sanz Moreno; J F Sánchez Ruiz; V Rausell Rausel; E Salas Martín; F Sánchez Rodríguez
Journal:  Aten Primaria       Date:  2002-05-31       Impact factor: 1.137

4.  [Effectiveness of an intervention strategy in the biosimilar glargine prescription pattern in primary care].

Authors:  Carmen Saborido-Cansino; Bernardo Santos-Ramos; Carmen Carmona-Saucedo; María Victoria Rodríguez-Romero; Antonio González-Martín; Ana Palma-Amaro; Isabel María Rojas-Lucena; Carmen Almeida-González; Susana Sánchez-Fidalgo
Journal:  Aten Primaria       Date:  2018-05-31       Impact factor: 1.137

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.